Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed1
Other3

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT04428918Withdrawn
Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation
Cell TransplantationHematologic MalignanciesHematopoietic Stem Cell Transplantation
PrincipalinvestigatorStart date: 2020-06-05
NCT04411134Phase 1Withdrawn
E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia
Cervical Intraepithelial Neoplasia
PrincipalinvestigatorStart date: 2020-05-28
NCT04044950Phase 2Withdrawn
A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer
Oropharyngeal NeoplasmsPapillomavirus Infections
PrincipalinvestigatorStart date: 2019-07-29
NCT02280811Phase 1/2Completed
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Anal CancerCervical CancerOropharyngeal Cancer+2 more
PrincipalinvestigatorStart date: 2014-10-14

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Cancer of the Uterine CervixAnal CancerHematologic Neoplasms+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score16%

Jun Zhang, master

Xiamen University

Related
12 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical DysplasiaAnal Cancer
Similarity Score8%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Hematopoietic Stem Cell TransplantationHematologic Neoplasms
Similarity Score5%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Cancer of the Uterine CervixUterine Cervical Dysplasia
Similarity Score5%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score3%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score3%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score3%

Xinghua Gao

First Hospital of China Medical University

Related
5 trials

Shared therapeutic areas:

Uterine Cervical Dysplasia
Similarity Score3%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Hematologic Neoplasms
Similarity Score3%

Meral Boşnak Güçlü, PhD

Gazi University

Related
10 trials

Shared therapeutic areas:

Hematopoietic Stem Cell Transplantation
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT04428918PrincipalInvestigator

Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation

Cell TransplantationHematologic MalignanciesHematopoietic Stem Cell Transplantation
Withdrawn
NCT04411134Phase 1PrincipalInvestigator

E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia

Cervical Intraepithelial Neoplasia
Withdrawn
NCT04044950Phase 2PrincipalInvestigator

A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer

Oropharyngeal NeoplasmsPapillomavirus Infections
Withdrawn
NCT02280811Phase 1/2PrincipalInvestigator

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Anal CancerCervical CancerOropharyngeal Cancer+2 more
Completed

All 4 trials loaded